QUANTUM-R Trademark

Trademark Overview

On Wednesday, July 15, 2015, a trademark application was filed for QUANTUM-R with the United States Patent and Trademark Office. The USPTO has given the QUANTUM-R trademark a serial number of 79173229. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 16, 2025. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The QUANTUM-R trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting of clinical studies and trials of pharmaceuticals for others; providing medical research information on clinical studies and trials of pharmaceuticals
quantum-r

General Information

Serial Number79173229
Word MarkQUANTUM-R
Filing DateWednesday, July 15, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 16, 2025
Registration Number5000675
Registration DateTuesday, July 19, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2016

Trademark Statements

Goods and ServicesConducting of clinical studies and trials of pharmaceuticals for others; providing medical research information on clinical studies and trials of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 3, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, October 1, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 6, 2015APPLICATION FILING RECEIPT MAILED
Monday, October 26, 2015ASSIGNED TO EXAMINER
Thursday, October 29, 2015NON-FINAL ACTION WRITTEN
Friday, October 30, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 5, 2015REFUSAL PROCESSED BY MPU
Thursday, November 5, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 20, 2015REFUSAL PROCESSED BY IB
Friday, March 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, March 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 13, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 3, 2016PUBLISHED FOR OPPOSITION
Tuesday, May 3, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, October 19, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 15, 2016FINAL DISPOSITION PROCESSED
Tuesday, November 15, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 2, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 19, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sunday, July 3, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, February 3, 2023CANCELLED SECTION 71
Tuesday, October 3, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, October 4, 2023INVALIDATION PROCESSED
Wednesday, October 4, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, October 23, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 29, 2026DEATH OF INTERNATIONAL REGISTRATION
Thursday, January 29, 2026NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

quantum trials studies pharmaceuticals clinical research information medical providing conducting others